12:00 AM
 | 
Jul 16, 2012
 |  BC Week In Review  |  Company News  |  Deals

BB Biotech AG deal

Swiss biotech fund BB Biotech rejected an offer from Swiss bank Vontobel Group to take it private. Vontobel said the offer is a 31.7% premium to the CHF81.95 BB Biotech...

Read the full 127 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >